Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
European Journal of Pharmacology
|
November 11, 2024
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
Alison C MacKinnon, Duncan C Humphries, Kimberley Herman, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 29, 2018
Hydrophobic Inorganic Oxide Pigments via Polymethylhydrosiloxane Grafting: Dispersion in Aqueous Solution at Extraordinarily High Solids Concentrations
Yijun Guo, Manish K Mishra, Futianyi Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 9, 2019
Gait worsening and the microlesion effect following deep brain stimulation for essential tremor
Ryan Roemmich, Jaimie A Roper, Robert S Eisinger, et al.
Frontiers in Rehabilitation Sciences
|
September 11, 2023
Characterization of initial ankle-foot prosthesis prescription patterns in U.S. Service members following unilateral transtibial amputation
Patrick G Monaghan, Ashley D Knight, Sarah A Brinkerhoff, et al.
Elife
|
November 13, 2020
<i>Smchd1</i> is a maternal effect gene required for genomic imprinting
Iromi Wanigasuriya, Quentin Gouil, Sarah A Kinkel, et al.
Journal of Medicinal Chemistry
|
December 12, 2024
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer
Kristoffer Peterson, Ulf J Nilsson, Lise Gravelle, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 Inhibitor
Fredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Frontiers in Human Neuroscience
|
March 18, 2021
Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson's Disease
Rene Molina, Chris J Hass, Stephanie Cernera, et al.
Haematologica
|
March 5, 2026
GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study
Richard F Schlenk, Claire N Harrison, Francesca Palandri, et al.
Journal of Medicinal Chemistry
|
September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Fredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
European Journal of Pharmacology
|
November 11, 2024
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
Alison C MacKinnon, Duncan C Humphries, Kimberley Herman, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 29, 2018
Hydrophobic Inorganic Oxide Pigments via Polymethylhydrosiloxane Grafting: Dispersion in Aqueous Solution at Extraordinarily High Solids Concentrations
Yijun Guo, Manish K Mishra, Futianyi Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 9, 2019
Gait worsening and the microlesion effect following deep brain stimulation for essential tremor
Ryan Roemmich, Jaimie A Roper, Robert S Eisinger, et al.
Frontiers in Rehabilitation Sciences
|
September 11, 2023
Characterization of initial ankle-foot prosthesis prescription patterns in U.S. Service members following unilateral transtibial amputation
Patrick G Monaghan, Ashley D Knight, Sarah A Brinkerhoff, et al.
Elife
|
November 13, 2020
<i>Smchd1</i> is a maternal effect gene required for genomic imprinting
Iromi Wanigasuriya, Quentin Gouil, Sarah A Kinkel, et al.
Journal of Medicinal Chemistry
|
December 12, 2024
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer
Kristoffer Peterson, Ulf J Nilsson, Lise Gravelle, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 Inhibitor
Fredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Frontiers in Human Neuroscience
|
March 18, 2021
Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson's Disease
Rene Molina, Chris J Hass, Stephanie Cernera, et al.
Haematologica
|
March 5, 2026
GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study
Richard F Schlenk, Claire N Harrison, Francesca Palandri, et al.
Journal of Medicinal Chemistry
|
September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Fredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Page
of 21